Novel Mutations in CEBPA in Korean Patients with Acute Myeloid Leukemia with a Normal Karyotype

Mutations in the transcription factor CCAAT/enhancer binding protein α gene (CEBPA) are found in 5-14% of the patients with AML and have been associated with a favorable clinical outcome. In this study, we aimed to assess the frequencies and characteristics of mutations in CEBPA. Between 2006 and 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sollip, Kim, Dong-Hwan (Dennis), Jang, Jun-Ho, Jung, Chul-Won, Jang, Mi-Ae, Ki, Chang-Seok, Kim, Jong-Won, Kim, Sun-Hee, Kim, Hee-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2012
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289781/
https://www.ncbi.nlm.nih.gov/pubmed/22389883
http://dx.doi.org/10.3343/alm.2012.32.2.153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3289781/
https://www.ncbi.nlm.nih.gov/pubmed/22389883
http://dx.doi.org/10.3343/alm.2012.32.2.153

Ejemplares similares